Please assess the completion status of the following clinical trial:

Trial Title: The Development of a Mother/Child, Screen, Treat and Vaccinate Program in Manchay and Iquitos, Peru

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Inclusion criteria (adult)~1. Non pregnant women 30-45 years of age in Manchay, and in Iquitos, with female children or grandchildren ages 10-13 who they are willing to enroll in the study to receive Gardasil vaccination.~2. No screening or knowledge of the results of a Pap Test in the last 5 years~3. No hysterectomy~4. No prior pelvic radiation.~5. Willing to sign consent form~Inclusion criteria (children)~1. Female children and grandchildren of a participating women ages 10-13 years~2. No acute illnesses (clinically evident according to vaccinating staff) - such as fever, nausea, vomiting, diarrhea~3. No previous vaccination with Gardasil~4. No reactions to previous dose in their vaccination series~5. No known yeast allergy~6. Willing to participate~Exclusion Criteria:~Exclusion criteria (adults)~Patients will be excluded in the study based on the following criteria:~1. Males~2. Women younger than 30 years old and older than 45 years old.~3. Women without female children or grandchildren age 10-13 or who are unwilling to enroll their 10-13 year old female children or grandchildren to receive Gardasil.~4. Pregnant women.~5. Patients with known history of hysterectomy or radiation for a pelvic cancer.~6. Refusal to participate~Exclusion criteria (Children)~1. Males~2. Girls younger than 10 years old, and older than 13 years.~3. acute illnesses (clinically evident according to vaccinating staff) - such as fever, nausea, vomiting, diarrhea~4. previous vaccination with Gardasil~5. reactions to a previous dose in their vaccination series~6. known yeast allergy~7. Refusal to participate

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).